S&P 500 7,580.07 −1.82%
Nasdaq 25,437.00 −2.86%
S&P/TSX 35,620.03 −1.74%
Apple 344.63 −1.23%
Nvidia 204.64 −4.22%
Microsoft 521.91 −1.55%
Shopify 220.37 −5.70%
Royal Bank 283.93 −1.49%
CAD/USD 0.7157 +0.10%
CLOSED · 02:30 ET
Market ClerkRecap
Sat Oct 31 · markets closed3 signals on Oct 30129 insider buys this week · $10BCIRO short report next: Nov 14The week ahead
MK
INSIDER · INBX · Inhibrx Biosciences, Inc. · DIRECTOR

MANHARD KIMBERLY

Every open-market transaction filed under this name, Sep 8 to Sep 15.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$279K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 15INBXInhibrx Biosciences, Inc.DirectorSell500$105.05$53K—
Sep 14INBXInhibrx Biosciences, Inc.DirectorSell500$110.26$55K—
Sep 11INBXInhibrx Biosciences, Inc.DirectorSell500$111.78$56K—
Sep 9INBXInhibrx Biosciences, Inc.DirectorSell500$115.80$58K—
Sep 8INBXInhibrx Biosciences, Inc.DirectorSell500$115.14$58K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.